WGS: GeneDx Holdings Corp - Class A Company Profile & Statistics

About

GeneDx Holdings Corp. is at the forefront of transforming healthcare through its industry-leading exome and genome testing and interpretation, fueled by rare disease data sets. GeneDx Holdings Corp., formerly known as Sema4 Holdings Corp., is based in STAMFORD, Conn.

Info & Links

CEO

Katherine Stueland

Headquarters

333 Ludlow Street, North Tower, 6th Floor
Stamford, CT 06902, UNITED STATES

Auditor

Ernst & Young LLP

Share holders

Employees

1,000

GeneDx Holdings Corp - Class A Statistics

Valuation Measures

Market Capitalization²

2.12B

Enterprise Value

2.12B

Enterprise Value/EBITDA(ttm)

-60.16

Price to Earnings Ratio(ttm)

Price to Sales(ttm)

7.74

Price to Book(mrq)

10.11

Price to Cash(ytd)

Profitability

Gross Margin(ttm)

59.16%

Operating Margin(ttm)

-10.41%

Profit Margin(ttm)

-32.37%

Return on Equity(ttm)

-13.35%

Return on Invested Capital(ttm)

-32.07%

Return on Assets(ttm)

-6.91%

Income Statement

Revenue(ttm)

267.23M

Revenue Per Share(ttm)

9.73

Gross Profit(ttm)

158.95M

EBITDA(ttm)³

-35.17M

Net Income Available to Common(ttm)

-83.50M

Diluted EPS(ttm)

-3.11

Share Statistics

Beta (5Y Monthly)

2.03

52-Week Change

4348.28%

S&P 500 52-Week Change

24.74%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding¹

27.47M

Dividend Yield

0.00%

Float⁴

19.97M

% Held by Insiders

27.30%

% Held by Institutions

61.72%

Balance Sheet

Total Cash(mrq)

116.46M

Total Cash Per Share(mrq)

4.24

Total Debt(mrq)

52.03M

Total Debt/Equity(mrq)

25.44%

Current Ratio(mrq)

2.40%

Quick Ratio(mrq)

2.27%

Book Value Per Share(mrq)

7.45

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.93

Free Cash Flow(ytd)

-27.75M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

WGS

GeneDx Holdings Corp - Class A

GeneDx Holdings Corp - Class A Profile